Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers

Authors: Moustafa, Manar; Bullock, Anthony J; Creagh, Fionuala M; Heller, Simon; Jeffcoate, William; Game, Frances; Amery, Carol; Tesfaye, Soloman; Ince, Zoe; Haddow, David B; MacNeil, Sheila

Source: Regenerative Medicine, Volume 2, Number 6, November 2007 , pp. 887-902(16)

Publisher: Future Medicine

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

<bold>Aim</bold>: To compare the rate of healing of diabetic neuropathic ulcers using cultured autologous keratinocytes delivered on chemically defined transfer discs (Myskin™™) (active treatment) versus healing obtained with cell-free discs (placebo). <bold>Materials and methods:</bold> After a 4-week lead-in period patients (randomly assigned) received active or placebo treatments weekly for 6 weeks. All patients then received active treatments for a maximum of 12 treatments where required. Altogether, 16 patients with a total of 21 ulcers resistant to conventional therapy were recruited from four specialist diabetic centers in three cities. <bold>Results:</bold> All 21 ulcers were treated and of these ten healed and eight improved, with two failing to respond (one ulcer was lost due to autoamputation). For analysis according to the study criteria, however, only the 12 patients with 12 index ulcers who completed treatment protocols were eligible -- five in the placebo group and seven in the active group. Of these, five ulcers healed completely and seven were reduced by more than 50%. Complete healing took a median of ten active applications. <bold>Conclusions:</bold> Repeated regular applications of the patient''s keratinocytes, delivered on the carrier dressing, initiated wound healing in ulcers resistant to conventional therapy, with 18 out of 21 ulcers responding. The healing observed did not appear attributable to patient recruitment or the cell-free carrier dressing but to the delivery of the cultured cells.

Keywords: cell delivery; keratinocytes; myskin™™; ulcers

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17460751.2.6.887

Affiliations: 1: 1Northern General Hospital, Division of Clinical Sciences (North), School of Medicine, Sheffield, S5 7AU, UK

Publication date: 2007-11-01

More about this publication?

Regenerative Medicine provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats vital to an increasingly time-constrained community.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites

Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages